The identification of two subgroups of obese women with differing endometrial proliferation levels: potential consequences in the development of endometrial cancer
dc.contributor.author | Villavicencio, A. | |
dc.contributor.author | Aguilar, G. | |
dc.contributor.author | Acuna, J. | |
dc.contributor.author | Gabler, F. | |
dc.contributor.author | Soto, E. | |
dc.contributor.author | Gaete, F. | |
dc.contributor.author | Penaloza, P. | |
dc.contributor.author | Celis, M. | |
dc.contributor.author | Owen, G. I. | |
dc.date.accessioned | 2025-01-20T23:57:30Z | |
dc.date.available | 2025-01-20T23:57:30Z | |
dc.date.issued | 2012 | |
dc.description.abstract | Enhanced endometrial proliferation correlates obesity to type-I (estrogen-dependent) endometrial cancer (EC). Our aim was to distinguish obese women (without EC) with differing endometrial proliferation. Endometrial and blood samples were obtained from normal-weight and obese women without EC. Type-I EC samples were obtained from obese patients. On measuring endometrial proliferation (Ki67 and phosphorylated histone H3 (p-H3)), two groups of obese women without EC were identified: obese(High Proliferating) (O-HP) and obese(Low Proliferating) (O-LP). Increased Ki67 (88.5%, P<0.001), p-H3 (62.6%, P<0.01), 17 beta-estradiol/progesterone ratio (46.3%, P<0.01) and endometrial estrogen receptor alpha (ER alpha) (82.2%, P<0.001) were observed in O-HP compared with O-LP patients. ECs possessed similar ER alpha and enhanced proliferation as O-HP, suggesting that O-HP women are at higher risk of type-I EC. O-LP women were indistinguishable from normal-weight women regarding these determinants of endometrial proliferation, ER alpha and 17 beta-estradiol/progesterone ratio. Our data may further define the obesity phenotype in regards to type-I EC risk and may help identify obese women more susceptible to develop type-I EC, allowing early intervention and a potential reduction in mortality. | |
dc.description.funder | Fondo Nacional de Desarrollo Cientifico y Tecnologico | |
dc.fuente.origen | WOS | |
dc.identifier.doi | 10.1038/ijo.2011.189 | |
dc.identifier.issn | 0307-0565 | |
dc.identifier.uri | https://doi.org/10.1038/ijo.2011.189 | |
dc.identifier.uri | https://repositorio.uc.cl/handle/11534/95209 | |
dc.identifier.wosid | WOS:000306273300020 | |
dc.issue.numero | 7 | |
dc.language.iso | en | |
dc.pagina.final | 1015 | |
dc.pagina.inicio | 1012 | |
dc.revista | International journal of obesity | |
dc.rights | acceso restringido | |
dc.subject | endometrium | |
dc.subject | proliferation | |
dc.subject | estrogen | |
dc.subject | cancer | |
dc.subject.ods | 03 Good Health and Well-being | |
dc.subject.odspa | 03 Salud y bienestar | |
dc.title | The identification of two subgroups of obese women with differing endometrial proliferation levels: potential consequences in the development of endometrial cancer | |
dc.type | artículo | |
dc.volumen | 36 | |
sipa.index | WOS | |
sipa.trazabilidad | WOS;2025-01-12 |